THE BUSINESS OF BIOTECH

52:20 24_01_BoB_1280x720_Ep244
BoB@JPM: Rick Modi, Affinia Therapeutics

The latest in our series of Business of Biotech podcasts recorded in-person at JPM in San Francisco features an inspiring conversation with Affinia Therapeutics CEO Rick Modi. Modi shares on how his upbringing in Kenya shaped his adversity-embracing worldview, and ho...

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Rick Modi
Affinia Therapeutics
PLAY
Brad Sitko
XOMA Royalty
PLAY
Owen Hughes
XOMA Royalty
PLAY
Thomas Chalberg
Genascence
PLAY
Ran Zheng
Landmark Bio
PLAY
Peter Anastasiou
Capsida Biotherapeutics
PLAY
Stefan Scherer
3T Bioscience
PLAY
Jim Doherty
Acumen Pharmaceuticals
PLAY
Andrey Doronichev
BIOPTIC
PLAY
Jeff Coller
Johns Hopkins University RNA Innovation Center
PLAY
Michelle Kim
Johns Hopkins University RNA Innovation Center
PLAY
Tal Zaks
Exsilio Therapeutics
PLAY
Apple Spotify   YouTube

MEET THE HOST

Matty PHosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.

LINKEDIN SEND FEEDBACK

Interested in joining us on air? Contact us

bob-nl-tile-v2-350

RECENT EPISODES

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

47:50 24_01_BoB_1280x720_Ep238

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

1:13:36 24_01_BoB_1280x720_Ep237

High-Throughput Discovery With BIOPTIC's Andrey Dobry

1:06:32 24_01_BoB_1280x720_Ep236

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

More Recent Episodes

FINANCE & CAPITAL MARKETS

57:48 24_01_BoB_1280x720_Ep174

The Legend Steve Gorlin's Golden Rules

1:04:44 24_01_BoB_1280x720_Ep213

The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.

1:01:57 24_01_BoB_1280x720_Ep170

Veteran Advice From The C-Suite With Citius' Leonard Mazur

37:47 24_01_BoB_1280x720_Ep152

The Innovation Reduction Act With Allan Shaw

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

44:41 24_01_BoB_1280x720_Ep63

From Bayer To Startup Bio With AltruBio's Dr. Judy Chou

49:48 24_01_BoB_1280x720_Ep111

Biotech M&A Anomalies With Allan Shaw

1:03:40 24_01_BoB_1280x720_Ep179

Public Sector Forged, Private Sector Tested With Renovaro BioSciences' Mark Dybul, M.D.

1:08:42 24_01_BoB_1280x720_Ep180

IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel

More on Finance & Capital Markets

DISCOVERY

59:02 24_01_BoB_1280x720_Ep106

Changing The Diabetes Care Paradigm With Arecor's Dr. Sarah Howell

42:23 24_01_BoB_1280x720_Ep23

Bacterial Therapy: Modulation Of The Microbiome

30:44 24_01_BoB_1280x720_Ep97

Running Interference: RNAi With Silence Therapeutics' Craig Tooman

46:58 24_01_BoB_1280x720_Ep157

ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.

55:33 24_01_BoB_1280x720_Ep87

CAR T-cells For Ovarian Cancers with Anixa Biosciences' Amit Kumar, Ph.D.

58:06 24_01_BoB_1280x720_Ep208

Topical Ocular Biologics with Claris Bio's Clarke Atwell

52:40 24_01_BoB_1280x720_Ep112

Genetic Testing & Neurodegenerative Disorders With AviadoBio's Lisa Deschamps

48:35 24_01_BoB_1280x720_Ep54

A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

51:59 24_01_BoB_1280x720_Ep124

RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati

More on Discovery

REGULATORY

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

39:26 24_01_BoB_1280x720_Ep16

Data Quality & Master Files With Dr. Robert Hariri

41:26 BoB_Ep11

Taking ADCs Across The Finish Line

1:06:13 24_01_BoB_1280x720_Ep181

Biotech Down Under with BiomeBank's Dr. Sam Costello

45:26 24_01_BoB_1280x720_Ep230

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

37:39 BoB_Ep32_2

The FDA's Progressive Appeal ft. Allan Shaw

41:57 BoB_Ep85_2

Regulatory Harmonization With Aurion Biotech's Dr. Daniela Drago

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

59:37 24_01_BoB_1280x720_Ep214

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

More on Regulatory

MANUFACTURING

48:03 BoB_Ep68_2

The CDMO Capacity Crunch ft. Discovery Labs' Audrey Greenberg And Iovance Biotherapeutics' Sumit Verma

35:43 BoB_1280x720_Ep9

Solving The COVID-19 Workforce Crisis

33:26 BoB_Ep58_2

Cold Chain Integrity & Sustainability With Celyad Oncology's Thomas Lequertier

42:26 BoB_Ep41_2

Filling A Vaccine Void With Cue Biopharma's Dan Passeri, J.D.

43:23 24_01_BoB_1280x720_Ep28

Acepodia's Approach To ACC & CAR Manufacturing Scalability

55:06 BoB_Ep69_2

Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead

1:03:05 24_01_BoB_1280x720_Ep122

Product Vs. Platform With Surface's Vito Palombella, Ph.D. And Robert Ross, M.D.

1:03:50 24_01_BoB_1280x720_Ep231

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

45:06 24_01_BoB_1280x720_Ep82

A Hybrid mAb Manufacturing Model With John Glasspool

36:25 BoB_Ep66_2

CMC Developability Assessments For Rapid Ph.1 Entry With AltruBio's Gene Lee, Ph.D.

More on Manufacturing